Inovio Pharma (INO) Reports Q2 Loss of $0.83/sh
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.20 +4.35%
Financial Fact:
Loss from investment in affiliated entity: -958.14K
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Loss from investment in affiliated entity: -958.14K
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q2 EPS of ($0.83), versus ($0.30) reported last year. Revenue for the quarter came in at $237 thousand, versus $135.7 thousand reported last year.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
- Prenetics Global (PRE) Tops Q2 EPS by 18c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
